Magazine article from our research archive:

Can Sentinel Save Drug Development?

Broader access to health system data promises to revolutionize drug safety monitoring-and could expedite approval of new drugs

Presently, the only real postmarket surveillance in the pharmaceutical industry comes from passive, generally unreliable adverse event reports by doctors and pharmacists. But now Congress has instructed FDA to establish an active postmarket safety surveillance and analysis system. The new Sentinel System, part of the FDA Amendments Act (FDAAA), will expand FDA initiatives to access health information databases on an estimated 25 million patients by 2010, and 100 million by 2012. This more extensive monitoring system will detect drug safety signals much faster, and ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!